{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:41:43Z","timestamp":1781721703493,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neuro.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T17:30:02Z","timestamp":1412098202000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75NTR"],"prefix":"10.1016","volume":"45","author":[{"given":"Amy","family":"Friesland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Duenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2014.09.005_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1471-4159.2004.02475.x","article-title":"Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones","volume":"90","author":"Ahnert-Hilger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.09.005_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0896-6273(00)81175-7","article-title":"A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons","volume":"26","author":"Bito","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.09.005_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/0897715041269597","article-title":"Lesional expression of RhoA and RhoB following traumatic brain injury in humans","volume":"21","author":"Brabeck","year":"2004","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.neuro.2014.09.005_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1995.13.1.26","article-title":"Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial","volume":"13","author":"Cascinu","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0025","first-page":"358","article-title":"Activated RHOA and peripheral axon regeneration","volume":"212","author":"Cheng","year":"2008","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0030","doi-asserted-by":"crossref","first-page":"e7754","DOI":"10.1371\/journal.pone.0007754","article-title":"What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach","volume":"4","author":"Chomiak","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.1076595","article-title":"The neurotrophin receptor p75NTR as a positive modulator of myelination","volume":"298","author":"Cosgaya","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.09.005_bib0040","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1523\/JNEUROSCI.22-15-06570.2002","article-title":"Rho signaling pathway targeted to promote spinal cord repair","volume":"22","author":"Dergham","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0045","doi-asserted-by":"crossref","first-page":"22554","DOI":"10.1074\/jbc.273.35.22554","article-title":"cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha","volume":"273","author":"Dong","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1523\/JNEUROSCI.08-04-01454.1988","article-title":"The establishment of polarity by hippocampal neurons in culture","volume":"8","author":"Dotti","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0055","first-page":"361","article-title":"Activation of Rho after traumatic brain injury and seizure in rats","volume":"198","author":"Dubreuil","year":"2006","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1083\/jcb.200301080","article-title":"Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system","volume":"162","author":"Dubreuil","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0065","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1074\/jbc.M213066200","article-title":"Serine phosphorylation negatively regulates RhoA in vivo","volume":"278","author":"Ellerbroek","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.09.005_bib0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jvs.2009.05.017","article-title":"The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy","volume":"50","author":"Feng","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.neuro.2014.09.005_bib0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.1992.10.5.795","article-title":"Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity","volume":"10","author":"Gregg","year":"1992","journal-title":"J Clin Oncol"},{"issue":"Suppl. 4","key":"10.1016\/j.neuro.2014.09.005_bib0080","first-page":"iv45","article-title":"Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention","volume":"14","author":"Grisold","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/S12094-010-0474-z","article-title":"Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies","volume":"12","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0090","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1126\/science.270.5243.1842","article-title":"Solution structure of a cisplatin-induced DNA interstrand cross-link","volume":"270","author":"Huang","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2014.09.005_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuro.2008.04.008","article-title":"Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants","volume":"29","author":"James","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2014.09.005_bib0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuro.2009.12.010","article-title":"Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin","volume":"31","author":"James","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2014.09.005_bib0110","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1523\/JNEUROSCI.1264-04.2004","article-title":"Abl tyrosine kinase promotes dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho family small GTPases in hippocampal neurons","volume":"24","author":"Jones","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07558.x","article-title":"Therapy of chemotherapy-induced peripheral neuropathy","volume":"145","author":"Kaley","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00432-003-0524-9","article-title":"Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma","volume":"130","author":"Koeppen","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0125","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/MCB.24.12.5340-5352.2004","article-title":"SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway","volume":"24","author":"Kontaridis","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"Pt. 19","key":"10.1016\/j.neuro.2014.09.005_bib0130","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1242\/jcs.110.19.2417","article-title":"Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA","volume":"110","author":"Kranenburg","year":"1997","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187152708783885093","article-title":"Small molecule modulation of p75 neurotrophin receptor functions","volume":"7","author":"Longo","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuro.2014.09.005_bib0140","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","article-title":"Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death","volume":"26","author":"Massa","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2004.09.013","article-title":"Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity","volume":"18","author":"McDonald","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.09.005_bib0150","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1523\/JNEUROSCI.20-14-05329.2000","article-title":"Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons","volume":"20","author":"Nakayama","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/jco.2007.25.18_suppl.9114","article-title":"Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity","volume":"25","author":"Pace","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0b013e3181d5279e","article-title":"Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial","volume":"74","author":"Pace","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.09.005_bib0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","article-title":"Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy","volume":"21","author":"Pace","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0170","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/092986708786848569","article-title":"Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies","volume":"15","author":"Park","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuro.2014.09.005_bib0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1113\/jphysiol.1951.sp004655","article-title":"A theory of the effects of fibre size in medullated nerve","volume":"115","author":"Rushton","year":"1951","journal-title":"J Physiol (Lond)"},{"key":"10.1016\/j.neuro.2014.09.005_bib0180","first-page":"861","article-title":"Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth","volume":"23","author":"Routhier","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.neuro.2014.09.005_bib0185","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.4194","article-title":"cGMP-dependent protein kinase phosphorylates and inactivates RhoA","volume":"280","author":"Sawada","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuro.2014.09.005_bib0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1008211226339","article-title":"Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial","volume":"8","author":"Smyth","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0195","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1471-4159.2005.03564.x","article-title":"Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice","volume":"96","author":"Song","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.09.005_bib0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(03)00271-X","article-title":"Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis","volume":"113","author":"Sordella","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.neuro.2014.09.005_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/annonc\/mdf058","article-title":"Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer","volume":"13","author":"Strumberg","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-5-9","article-title":"Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli","volume":"5","author":"Ta","year":"2009","journal-title":"Mol Pain"},{"key":"10.1016\/j.neuro.2014.09.005_bib0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neuroscience.2004.10.022","article-title":"Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS)","volume":"131","author":"Tatsumi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.09.005_bib0220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0896-6273(00)80376-1","article-title":"Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42","volume":"19","author":"Threadgill","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.09.005_bib0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8","article-title":"Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice","volume":"22","author":"Verd\u00fa","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuro.2014.09.005_bib0230","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.4049\/jimmunol.168.8.4087","article-title":"Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis","volume":"168","author":"Walters","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.neuro.2014.09.005_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nn1045","article-title":"The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI","volume":"6","author":"Yamashita","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuro.2014.09.005_bib0240","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1090154","article-title":"Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho","volume":"302","author":"Zhou","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.09.005_bib0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199001113220204","article-title":"Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer","volume":"322","author":"van der Hoop","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuro.2014.09.005_bib0250","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/1097-0142(19901015)66:8<1697::AID-CNCR2820660808>3.0.CO;2-G","article-title":"Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin","volume":"66","author":"van der Hoop","year":"1990","journal-title":"Cancer"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14001673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14001673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:34:47Z","timestamp":1650285287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X14001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":50,"alternative-id":["S0161813X14001673"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2014.09.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75NTR","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}